Cargando…

The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System

Metabolic abnormalities such as dyslipidemia, hyperinsulinemia, or insulin resistance and obesity play key roles in the induction and progression of type 2 diabetes mellitus (T2DM). The field of immunometabolism implies a bidirectional link between the immune system and metabolism, in which inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daryabor, Gholamreza, Atashzar, Mohamad Reza, Kabelitz, Dieter, Meri, Seppo, Kalantar, Kurosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387426/ https://www.ncbi.nlm.nih.gov/pubmed/32793223 http://dx.doi.org/10.3389/fimmu.2020.01582

Ejemplares similares

Immune responses in mildly versus critically ill COVID-19 patients
por: Nasrollahi, Hamid, et al.
Publicado: (2023)

Th-1, Th-2, Th-9, Th-17, Th-22 type cytokine concentrations of critical COVID-19 patients after treatment with Remdesivir
por: Kalantar, Kurosh, et al.
Publicado: (2023)

Regulation of the Complement System by Pentraxins
por: Haapasalo, Karita, et al.
Publicado: (2019)

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)

Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits
por: Meri, Seppo, et al.
Publicado: (2020)

SALSA: A Regulator of the Early Steps of Complement Activation on Mucosal Surfaces
por: Reichhardt, Martin Parnov, et al.
Publicado: (2016)

Editorial: “Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives”
por: Kabelitz, Dieter, et al.
Publicado: (2015)

Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders
por: Vakili, Mahsa Eshkevar, et al.
Publicado: (2022)

The m6A methylation profiles of immune cells in type 1 diabetes mellitus
por: Wang, Yimeng, et al.
Publicado: (2022)

Chemokines in Type 1 Diabetes Mellitus
por: Pan, Xiongfeng, et al.
Publicado: (2022)

The outer membrane protease PgtE of Salmonella enterica interferes with the alternative complement pathway by cleaving factors B and H
por: Riva, Rauna, et al.
Publicado: (2015)

Editorial: Function and Dysfunction of Complement Factor H
por: Józsi, Mihály, et al.
Publicado: (2022)

Immunology Education Without Borders
por: Kabelitz, Dieter, et al.
Publicado: (2019)

Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells
por: Oberg, Hans-Heinrich, et al.
Publicado: (2019)

Gestational Diabetes Mellitus Changes Human Colostrum Immune Composition
por: Avellar, Ana Carolina de Sena, et al.
Publicado: (2022)

Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity
por: Chen, Jingxian, et al.
Publicado: (2023)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria—Return to Health or Transition Into Malignancy?
por: Korkama, Eva-Stina, et al.
Publicado: (2018)

Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
por: Bhat, Jaydeep, et al.
Publicado: (2018)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation
por: Leimi, Lilli, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in Uganda
por: Ssekamatte, Phillip, et al.
Publicado: (2021)

Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes
por: Ding, Qiyou, et al.
Publicado: (2022)

Adipokines as potential biomarkers for type 2 diabetes mellitus in cats
por: Sierawska, Olga, et al.
Publicado: (2022)

Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
por: Lu, Shen, et al.
Publicado: (2023)

Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery
por: Livson, Sivan, et al.
Publicado: (2021)

Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
por: Livson, Sivan, et al.
Publicado: (2022)

The salivary scavenger and agglutinin binds MBL and regulates the lectin pathway of complement in solution and on surfaces
por: Reichhardt, Martin P., et al.
Publicado: (2012)

Editorial: Extracellular vesicles in cancer immunosurveillance
por: Moloudizargari, Milad, et al.
Publicado: (2022)

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential
por: Que, Yanyan, et al.
Publicado: (2021)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)

Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus
por: Li, Dandan, et al.
Publicado: (2023)

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Plasma-derived exosomal mRNA profiles associated with type 1 diabetes mellitus
por: Fan, Wenqi, et al.
Publicado: (2022)

The bidirectional biological interplay between microbiome and viruses in periodontitis and type-2 diabetes mellitus
por: Tang, Boyu, et al.
Publicado: (2022)

Chemokines in Gestational Diabetes Mellitus
por: Liu, Hongying, et al.
Publicado: (2022)

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
por: Boniface, Katia, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases
por: Li, Xuan, et al.
Publicado: (2017)

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome
por: Marsiglio, John, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mq28n5qrfqvl1t8hjr6opr7hvr